SELLAS SLS stock has a bullish daily bias, but overbought readings complicate the case for further gains. SELLAS Life Sciences Group trades above its daily averages and upper Bollinger band following positive Phase 3 REGAL results. However, the averages do not yet form a fully bullish sequence.

Key takeaways

  • SELLAS SLS stock was trading at $20.87 as of 11:22 ET on Tuesday, up 179.38% from the previous close, with 1,805,615 shares traded so far.

  • The stock stands above its 20-session EMA ($10.33), 50-session EMA ($10.82), and 200-session EMA ($9.12), but the 20-session average remains below the 50-session average.

  • Daily RSI14 is 78.64, in overbought territory; hourly RSI14 is 93.49; and 15-minute RSI14 is 81.78.

  • Price is above the daily upper Bollinger band at $15.84 and the hourly upper Bollinger band at $16.49.

  • The stock sits above the 15-minute pivot ($20.53) and hourly pivot ($20.34) but below 15-minute first resistance ($21.1).

On Tuesday, November 17, 2026, shares opened at $24.11 and traded between a low of $16.76 and a high of $24.87. The stock was trading at $20.87 as of 11:22 ET, up 179.38% versus the previous close, with 1,805,615 shares traded so far. The session remains open. The daily candle opened at $24.11, traded between a low of $16.76 and a high of $24.87, and was last at $20.87, against a previous close of $7.47.

REGAL results provide the news context

In a release published before Tuesday’s open, SELLAS reported that its Phase 3 REGAL trial of galinpepimut-S met its primary endpoint of overall survival. The company described a statistically significant and clinically meaningful improvement in patients with acute myeloid leukemia. Those results provide the central news context, while the chart shows an overbought stock rather than an uncomplicated bullish setup.

SELLAS SLS stock: Daily strength without full trend alignment

The daily chart sets the positive directional bias. Price stands above the 20-session EMA at $10.33, the 50-session EMA at $10.82, and the 200-session EMA at $9.12. However, the 20-session average remains below the 50-session average, so the full bullish ordering is absent.

Meanwhile, daily RSI14 stands at 78.64, in overbought territory. The MACD line is 0.07, above its signal at -0.66, with a positive histogram of 0.73. Momentum therefore supports the bullish case, but RSI warns against treating that support as evidence of an unextended position.

Price also stands above the daily upper Bollinger band at $15.84, placing it outside the band envelope. Daily ATR14 increased to $2.15 from $0.98 on the preceding candle. That measured expansion in volatility makes the distance between nearby triggers and deeper daily reference levels important.

Hourly confirmation, with a short-term qualification

The hourly chart confirms the daily directional bias. Price sits above the hourly pivot at $20.34 and the hourly upper Bollinger band at $16.49. Hourly RSI14 is 93.49, in overbought territory, while the MACD line at 1.56 exceeds its signal at 0.31. The direction agrees with the daily chart; the overbought condition complicates timing.

In contrast, the 15-minute MACD histogram declined to 1.12 from 1.27 on the preceding candle, although it remains positive. The 15-minute RSI14 stands at 81.78, also overbought. This is a short-term qualification, not a bearish override of the daily view.

For execution context, price sits above the 15-minute pivot at $20.53 but below its first resistance at $21.1. These levels, calculated from the previous completed 15-minute candle, frame the immediate decision area. The hourly first resistance at $23.91 is a separate, higher reference.

Bullish and bearish scenarios

The bullish scenario requires price to hold above the 15-minute pivot at $20.53 and hourly pivot at $20.34. Clearing the 15-minute first resistance at $21.1 would support that case. The next higher references are hourly first resistance at $23.91, the 15-minute upper Bollinger band at $24.7, and the session high at $24.87.

Conversely, a break below $20.53 and then $20.34 would weaken immediate bullish control. The next lower reference is 15-minute first support at $20.23. A break below the session low at $16.76 would challenge the broader setup. Losing the daily upper band at $15.84 would invalidate the outside-band bullish case.

Overall, SELLAS SLS stock stands above the nearby pivots but below immediate 15-minute resistance. Daily volatility has expanded, and every timeframe carries an overbought RSI reading. The unresolved question is whether price can hold those intraday supports and clear resistance before the session ends.

FAQ

What is the current price of SELLAS SLS stock?

SELLAS SLS stock was trading at $20.87 as of 11:22 ET on Tuesday, up 179.38% from the previous close, with 1,805,615 shares traded so far. The session remains open.

Is SELLAS SLS stock currently overbought?

Overbought readings appear across all timeframes. Daily RSI14 is 78.64, hourly RSI14 is 93.49, and the 15-minute RSI14 is 81.78. All three are in overbought territory.

What are the key support and resistance levels for SLS?

The 15-minute pivot at $20.53 and hourly pivot at $20.34 are nearby supports. The 15-minute first resistance sits at $21.1, with hourly first resistance at $23.91. The session low is $16.76 and the daily upper Bollinger band is at $15.84.

What is the daily trend structure for SELLAS SLS stock?

The stock stands above its 20-session EMA ($10.33), 50-session EMA ($10.82), and 200-session EMA ($9.12). However, the 20-session average remains below the 50-session average, so the full bullish EMA sequence is absent.

Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.

Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.

Read also: Nebius Group stock closes at $134, 5.27% lower, below all three daily EMAs

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.